Ambrx Biopharma Cayman, Inc.

Ownership Transactions Reported by 16 Insiders

Location
10975 North Torrey Pines Road, La Jolla, CA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Ambrx Biopharma Cayman, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $642M Sep 15, 2023
HOPU Reunion Co Ltd 10%+ Owner $360M Jan 1, 2023
Commodore Capital Lp 10%+ Owner $330M Feb 23, 2023
Darwin Global Management, Ltd. 10%+ Owner $306M Jun 27, 2023
WuXi AppTec Co., Ltd. 10%+ Owner $271M Jan 1, 2023
Edward Hu Director $11.2M Jan 1, 2023
Kate Hermans Director $786K Jun 7, 2023
Janet Loesberg Director $786K Jun 7, 2023
Paul V. Maier Director $786K Jun 7, 2023
Stephen C. Glover Director $786K May 18, 2023
Margaret Dalesandro Director $655K Sep 1, 2023
Xiaowei Chang Director Jun 7, 2023
Sonja Nelson Chief Financial Officer Jul 5, 2023
Andrew Aromando Chief Operating Officer Jul 5, 2023
Katrin Rupalla Director Jan 27, 2023
Daniel J. O'Connor President and CEO, Director Jul 5, 2023

Recent Insider Transactions by Companies or Individuals for Ambrx Biopharma Cayman, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.